# Study of Artemether-lumefantrine, Amodiaquine and Primaquine in Healthy Subjects

> **NCT02696954** · PHASE1,PHASE2 · TERMINATED · sponsor: **University of Oxford** · enrollment: 17 (actual)

## Conditions studied

- Pharmacokinetic
- Drug Combination
- Healthy

## Interventions

- **DRUG:** Artemether-lumefantrine
- **DRUG:** Amodiaquine
- **DRUG:** Artemether-lumefantrine
- **DRUG:** Artemether-lumefantrine + Amodiaquine
- **DRUG:** Primaquine
- **DRUG:** Artemether-lumefantrine + Primaquine
- **DRUG:** Artemether-lumefantrine + Amodiaquine + Primaquine
- **DRUG:** Artemether-lumefantrine + Primaquine

## Key facts

- **NCT ID:** NCT02696954
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-11-18
- **Primary completion:** 2019-03
- **Final completion:** 2019-03
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2019-06-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02696954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02696954, "Study of Artemether-lumefantrine, Amodiaquine and Primaquine in Healthy Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02696954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*